secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001048477-25-000098
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin Chief Accounting Officer Erin Burkhart resigns; CFO to serve as interim principal accounting officer
--------------------------------------------------------------------------------

- Erin Burkhart notified her resignation as Chief Accounting Officer, effective September 2, 2025; departure is voluntary with no disagreement.
- BioMarin will conduct a search for a successor; if none is appointed by the Effective Date, CFO Brian Mueller will serve as principal accounting officer.
- Mueller will remain Executive VP and CFO with no additional compensation or adjustments for assuming the principal accounting officer duties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/0001048477-25-000098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/bmrn-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001048477-25-000098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer